The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity

Anti-HER2/neu antibody therapy is reported to mediate tumor regression by interrupting oncogenic signals and/or inducing FcR-mediated cytotoxicity. Here, we demonstrate that the mechanisms of tumor regression by this therapy also require the adaptive immune response. Activation of innate immunity an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, SaeGwang, Jiang, Zhujun, Mortenson, Eric D., Deng, Liufu, Radkevich-Brown, Olga, Yang, Xuanming, Sattar, Husain, Wang, Yang, Brown, Nicholas K., Greene, Mark, Liu, Yang, Tang, Jie, Wang, Shengdian, Fu, Yang-Xin
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2923645/
https://ncbi.nlm.nih.gov/pubmed/20708157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2010.06.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados